返回
Repare Therapeutics Inc（RPTX）價格
RPTX 股價走勢圖
RPTX 收益
Repare Therapeutics Inc
$2.65
0.76%
$0.02
收盤價：Jan 27, 16:00:00 GMT-5
$2.64
-0.36%
$0
盤後：Jan 27, 20:00:00 GMT-5
關鍵數據
前收市價
$2.63
開盤價
$2.64
當日範圍
$2.62 - $2.65
52週區間
$0.89 - $2.66
交易量
1.1M
平均成交量
1.1M
每股盈餘 (TTM)
-1.69
股息收益率
--
市值
$113.5M
什麼是 RPTX？
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company is headquartered in St-Laurent, Quebec and currently employs 129 full-time employees. The company went IPO on 2020-06-19. The firm utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.